Samanta, Jayshree http://orcid.org/0000-0003-1240-3395
Silva, Hernandez Moura
Lafaille, Juan J.
Salzer, James L.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS100867)
Article History
Received: 8 December 2020
Accepted: 10 September 2021
First Online: 28 October 2021
Competing interests
: A patent on the method of targeting GLI1 as a strategy to promote remyelination has been awarded, with J. L. Salzer, J. Samanta and G. Fishell listed as co-inventors. JLS is a consultant for and has ownership interests in Glixogen Therapeutics.